Prolonged spinal loading induces matrix metalloproteinase-2 activation in intervertebral discs

Spine

Volumn 28, Issue 16, 2003, Pages 1781-1788

  Hsieh, Adam H ^b   Lotz, Jeffrey C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Animal model; Intervertebral disc; Matrix metalloproteinase; Mechanical loading; RT PCR

Indexed keywords

BETA ACTIN; GELATINASE A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DEGENERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION;

ANIMALS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTERVERTEBRAL DISK; MALE; MATRIX METALLOPROTEINASE 2; MICE; MODELS, ANIMAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINE; STRESS, MECHANICAL; TIME FACTORS; WEIGHT-BEARING;

EID: 0042975388     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.BRS.0000083282.82244.F3     Document Type: Article

References (81)

1. Buckwalter JA. Aging and degeneration of the human intervertebral disc. Spine 1995;20:1307-14.
2. Inoue H. Three-dimensional architecture of lumbar intervertebral discs. Spine 1981;6:139-46.
3. Miyamoto S, Yonenobu K, Ono K. Experimental cervical spondylosis in the mouse. Spine 1991;16:S495-500.
4. Thompson JP, Pearce RH, Schechter MT, et al. Preliminary evaluation of a scheme for grading the gross morphology of the human intervertebral disc. Spine 1990;15:411-5.
5. Lyons G, Eisenstein SM, Sweet MB. Biochemical changes in intervertebral disc degeneration. Biochim Biophys Acta 1981;673:443-53.
6. Hutton WC, Elmer WA, Boden SD, et al. Analysis of chondroitin sulfate in lumbar intervertebral discs at two different stages of degeneration as assessed by discogram. J Spinal Disord 1997;10:47-54.
7. Antoniou J, Steffen T, Nelson F, et al. The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, aging, and degeneration. J Clin Invest 1996;98:996-1003.
8. Gruber HE, Hanley EN Jr. Observations on morphologic changes in the aging and degenerating human disc: Secondary collagen alterations. BMC Musculoskelet Disord 2002;3:9.
9. Adams MA, McNally DS, Dolan P. "Stress" distributions inside intervertebral discs. The effects of age and degeneration. J Bone Joint Surg Br 1996; 78:965-72.
10. Burton AK, Battié MC, Gibbons L, et al. Lumbar disc degeneration and sagittal flexibility. J Spinal Disord 1996;9:418-24.
11. Fujita Y, Duncan NA, Lotz JC. Radial tensile properties of the lumbar annulus fibrosus are site and degeneration dependent. J Orthop Res 1997;15:814-9.
12. Iatridis JC, Setton LA, Foster RJ, et al. Degeneration affects the anisotropic and nonlinear behaviors of human anulus fibrosus in compression. J Biomech 1998;31:535-44.
13. Gu WY, Mao XG, Foster RJ, et al. The anisotropic hydraulic permeability of human lumbar anulus fibrosus. Influence of age, degeneration, direction, and water content. Spine 1999;24:2449-55.
14. Basbaum CB, Werb Z. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol 1996;8:731-8.
15. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999; 274:21491-4.
16. Weiler C, Nerlich AG, Zipperer J, et al. 2002 SSE Award Competition in Basic Science: expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption. Eur Spine J 2002;11:308-20.
17. Nishida T. Kinetics of tissue and serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 in intervertebral disc degeneration and disc herniation. Kurume Med J 1999;46:39-50.
18. Nemoto O, Yamagishi M, Yamada H, et al. Matrix metalloproteinase-3 production by human degenerated intervertebral disc. J Spinal Disord 1997;10:493-8.
19. Roberts S, Caterson B, Menage J, et al. Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine 2000;25:3005-13.
20. Liu J, Roughley PJ, Mort JS. Identification of human intervertebral disc stromelysin and its involvement in matrix degradation. J Orthop Res 1991;9:568-75.
21. Kanemoto M, Hukuda S, Komiya Y, et al. Immunohistochemical study of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 human intervertebral discs. Spine 1996;21:1-8.
22. Kang JD, Georgescu HI, McIntyre-Larkin L, et al. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine 1996;21:271-7.
23. Kang JD, Georgescu HI, McIntyre-Larkin L, et al. Herniated cervical intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine 1995;20:2373-8.
24. Kang JD, Stefanovic-Racic M, McIntyre LA, et al. Toward a biochemical understanding of human intervertebral disc degeneration and herniation. Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases. Spine 1997;22:1065-73.
25. Sztrolovics R, Alini M, Roughley PJ, et al. Aggrecan degradation in human intervertebral disc and articular cartilage. Biochem J 1997;326:235-41.
26. Matsui Y, Maeda M, Nakagami W, et al. The involvement of matrix metalloproteinases and inflammation in lumbar disc herniation. Spine 1998;23: 863-8; discussion 68-9.
27. Baba H, Maezawa Y, Furusawa N, et al. Herniated cervical intervertebral discs: histological and immunohistochemical characteristics. Eur J Histochem 1997;41:261-70.
28. Haro H, Shinomiya K, Murakami S, et al. Up-regulated expression of matrilysin and neutrophil collagenase in human herniated discs. J Spinal Disord 1999;12:245-9.
29. Doita M, Kanatani T, Ozaki T, et al. Influence of macrophage infiltration of herniated disc tissue on the production of matrix metalloproteinases leading to disc resorption. Spine 2001;26:1522-7.
30. Sakuma M, Fujii N, Takahashi T, et al. Effect of chondroitinase ABC on matrix metalloproteinases and inflammatory mediators produced by intervertebral disc of rabbit in vitro. Spine 2002;27:576-80.
31. Haro H, Crawford HC, Fingleton B, et al. Matrix metalloproteinase-7-dependent release of tumor necrosis factor- alpha in a model of herniated disc resorption. J Clin Invest 2000;105:143-50.
32. Haro H, Crawford HC, Fingleton B, et al. Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption. J Clin Invest 2000;105:133-41.
33. Furusawa N, Baba H, Miyoshi N, et al. Herniation of cervical intervertebral disc: immunohistochemical examination and measurement of nitric oxide production. Spine 2001;26:1110-6.
34. Crean JK, Roberts S, Jaffray DC, et al. Matrix metalloproteinases in the human intervertebral disc: role in disc degeneration and scoliosis. Spine 1997;22:2877-84.
35. Lotz JC, Colliou OK, Chin JR, et al. Compression-induced degeneration of the intervertebral disc: an in vivo mouse model and finite-element study. Spine 1998;23:2493-506.
36. Lotz JC, Chin JR. Intervertebral disc cell death is dependent on the magnitude and duration of spinal loading. Spine 2000;25:1477-83.
37. Walsh AJL, Lotz JC. Biological response of the intervertebral disc to dynamic loading. J Biomech, submitted.
38. Hutton WC, Toribatake Y, Elmer WA, et al. The effect of compressive force applied to the intervertebral disc in vivo. A study of proteoglycans and collagen. Spine 1998;23:2524-37.
39. Hutton WC, Ganey TM, Elmer WA, et al. Does long-term compressive loading on the intervertebral disc cause degeneration? Spine 2000;25:2993-3004.
40. Ohshima H, Urban JP, Bergel DH. Effect of static load on matrix synthesis rates in the intervertebral disc measured in vitro by a new perfusion technique. J Orthop Res 1995;13:22-9.
41. Schollmeier G, Lewandrowski KU, Lahr-Eigen R, et al. Localization of fiber forming collagens in the human lumbar intervertebral disc: an immunohistochemical study. Trans Orthop Res Soc 1999;24:1028.
42. Antoniou J, Arlet V, Goswami T, et al. Elevated synthetic activity in the convex side of scoliotic intervertebral discs and endplates compared with normal tissues. Spine 2001;26:E198-206.
43. Court C, Colliou OK, Chin JR, et al. The effect of static in vivo bending on the murine intervertebral disc. Spine J 2001;1:239-45.
44. Handa T, Ishihara H, Ohshima H, et al. Effects of hydrostatic pressure on matrix synthesis and matrix metalloproteinase production in the human lumbar intervertebral disc. Spine 1997;22:1085-91.
45. Yamazaki S, Banes AJ, Weinhold PS, et al. Vibratory loading decreases extracellular matrix and matrix metalloproteinase gene expression in rabbit annulus cells. Trans Orthop Res Soc 2002;27:818.
46. MacLean JJ, Lee CR, Grad S, et al. Effect of cyclic compression on intervertebral disc metabolism. International Society for the Study of the Lumbar Spine: 2002:72.
47. Shen JH, Ingraham HA. Regulation of the orphan nuclear receptor steroidogenic factor 1 by Sox proteins. Mol Endocrinol 2002;16:529-40.
48. Zar JH. Data transformations. In: Biostatistical Analysis. Upper Saddle River, NJ: Prentice-Hall, Inc.; 1999:273-81.
49. Sokal RR, Rohlf FJ. Biometry. New York, NY: W. H. Freeman and Co.; 1995.
50. Lambert CA, Colige AC, Munaut C, et al. Distinct pathways in the overexpression of matrix metalloproteinases in human fibroblasts by relaxation of mechanical tension. Matrix Biol 2001;20:397-408.
51. Blain EJ, Gilbert SJ, Wardale RJ, et al. Up-regulation of matrix metalloproteinase expression and activation following cyclical compressive loading of articular cartilage in vitro. Arch Biochem Biophys 2001;396:49-55.
52. Mudera VC, Pleass R, Eastwood M, et al. Molecular responses of human dermal fibroblasts to dual cues: contact guidance and mechanical load. Cell Motil Cytoskeleton 2000;45:1-9.
53. Steffensen B, Bigg HF, Overall CM. The involvement of the fibronectin type II-like modules of human gelatinase A in cell surface localization and activation. J Biol Chem 1998;273:20622-8.
54. Vankemmelbeke M, Dekeyser PM, Hollander AP, et al. Characterization of helical cleavages in type II collagen generated by matrixins. Biochem J 1998; 330:633-40.
55. Ireland D, Harrall R, Curry V, et al. Multiple changes in gene expression in chronic human Achilles tendinopathy. Matrix Biol 2001;20:159-69.
56. Hellio Le Graverand MP, Eggerer J, Sciore P, et al. Matrix metalloproteinase-13 expression in rabbit knee joint connective tissues: influence of maturation and response to injury. Matrix Biol 2000;19:431-41.
57. Carreon LY, Ito T, Yamada M, et al. Neovascularization induced by anulus and its inhibition by cartilage endplate. Its role in disc absorption. Spine 1997;22:1429-34; discussion 46-7.
58. Pattison ST, Melrose J, Ghosh P, et al. Regulation of gelatinase-A (MMP-2) production by ovine intervertebral disc nucleus pulposus cells grown in alginate bead culture by Transforming Growth Factor-beta(1)and insulin like growth factor-I. Cell Biol Int 2001;25:679-89.
59. Zhou Z, Apte SS, Soininen R, et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci USA 2000;97:4052-7.
60. Zucker S, Drews M, Conner C, et al. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 1998; 273:1216-22.
61. Strongin AY, Collier I, Bannikov G, et al. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995;270:5331-8.
62. Overall CM, King AE, Sam DK, et al. Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis. The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV. J Biol Chem 1999;274:4421-9.
63. Overall CM, Tam E, McQuibban GA, et al. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation. J Biol Chem 2000;275:39497-506.
64. Wang Z, Juttermann R, Soloway PD. TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 2000;275:26411-5.
65. Butler GS, Butler MJ, Atkinson SJ, et al. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 1998;273:871-80.
66. Morrison CJ, Butler GS, Bigg HF, et al. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2 -independent pathway. J Biol Chem 2001;276:47402-10.
67. Ellerbroek SM, Wu YI, Overall CM, et al. Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J Biol Chem 2001;276:24833-42.
68. Tomasek JJ, Halliday NL, Updike DL, et al. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J Biol Chem 1997;272:7482-7.
69. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000;1477: 267-83.
70. Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem 1991;266:13070-5.
71. Bigg HF, Morrison CJ, Butler GS, et al. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Cancer Res 2001; 61:3610-8.
72. Hernandez-Barrantes S, Shimura Y, Soloway PD, et al. Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP. Biochem Biophys Res Commun 2001;281:126-30.
73. Rittie L, Berton A, Monboisse JC, et al. Decreased contraction of glycated collagen lattices coincides with impaired matrix metalloproteinase production. Biochem Biophys Res Commun 1999;264:488-92.
74. Knäuper V, Will H, López-Otin C, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996;271:17124-31.
75. Roeb E, Winograd R, Breuer B, et al. Increased TIMP-1 activity results in increased expression of gelatinases and altered cell motility. J Cell Biochem 1999;75:346-55.
76. Deryugina EI, Bourdon MA, Luo GX, et al. Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci 1997;110:2473-82.
77. Gearing AJ, Beckett P, Christodoulou M, et al. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 1994;370:555-7.
78. Shubayev VI, Myers RR. Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury. Brain Res 2000;855:83-9.
79. Shubayev VI, Myers RR. Endoneurial remodeling by TNFalpha- and TNFalpha-releasing proteases. A spatial and temporal co-localization study in painful neuropathy. J Peripher Nerv Syst 2002;7:28-36.
80. Igarashi T, Kikuchi S, Shubayev V, et al. 2000 Volvo Award winner in basic science studies: Exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine 2000;25:2975-80.
81. Onda A, Hamba M, Yabuki S, et al. Exogenous tumor necrosis factor-alpha induces abnormal discharges in rat dorsal horn neurons. Spine 2002;27: 1618-24.